Research map: Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study)

Back to the article

Papers in this map

  1. Amyotrophic lateral sclerosis · Eva L. Feldman · 2022 · 1131 citations · Cited by this paper
  2. First Reported Case of Dual Hereditary Gelsolin and Transthyretin Wild-Type Cardiac Amyloidosis in a Man in his late 40s · 2025 · Related
  3. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS · Jonathan S. Mill · 2022 · 942 citations · Cited by this paper
  4. Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis · 2026 · Related
  5. Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature · Adriano Chiò · 2013 · 870 citations · Cited by this paper
  6. Patterns of Glaucoma Treatment Use in Asian American Patients With Primary Open-Angle Glaucoma · 2026 · Related
  7. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis · Stephen A. Goutman · 2022 · 411 citations · Cited by this paper
  8. Pseudo-Index Events Cannot be Configured on the TriNetX Platform · 2026 · Related
  9. Amyotrophic lateral sclerosis: translating genetic discoveries into therapies · Fulya Akçimen · 2023 · 235 citations · Cited by this paper
  10. The Hidden Burden of Entheseal Pathology in Lower-Limb Pain: A Real-World Ultrasound Study of 667 Adults · 2026 · Related
  11. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS · Michael G Benatar · 2020 · 214 citations · Cited by this paper
  12. Minibeam Radiation Therapy for Recurrent Mucosal Melanoma: An Eye-Opening Response · 2025 · Related
  13. Immortal time bias in observational studies of time-to-event outcomes · Mark Jones · 2016 · 190 citations · Cited by this paper
  14. Treatment Modalities, Pain Response, and Referrals for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: A Retrospective Study · 2025 · Related
  15. SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis · Francesco Tafuri · 2015 · 165 citations · Cited by this paper
  16. Comparing Clinical Outcomes and Health Care Utilization: Telehealth Versus Traditional Care at US Rural Hemodialysis Units · 2025 · Related
  17. Diagnostic and Prognostic Performance of Neurofilaments in ALS · Koen Poesen · 2019 · 147 citations · Cited by this paper
  18. Nonsurgical Management of Abdominal Compartment Syndrome Using Transarterial Embolization and Percutaneous Catheter Drainage: A Case Report · 2025 · Related
  19. Effects of tofersen treatment in patients with SOD1-ALS in a “real-world” setting – a 12-month multicenter cohort study from the German early access program · Maximilian Wiesenfarth · 2024 · 120 citations · Cited by this paper
  20. Autonomic Symptoms in Post-Treatment Lyme Disease: Insights From the COMPASS-31 and the 10-Minute Active Stand Test · 2025 · Related
  21. Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007 · Benôıt Marin · 2009 · 50 citations · Cited by this paper
  22. Tofersen for SOD1 amyotrophic lateral sclerosis: a systematic review and meta-analysis · Abdullah Ashraf Hamad · 2025 · 36 citations · Cited by this paper
  23. Tofersen treatment leads to sustained stabilization of disease in SOD1 ALS in a “real‐world” setting · Sam Smith · 2025 · 33 citations · Cited by this paper
  24. Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis · Timothy M. Miller · 2026 · 32 citations · Cited by this paper
  25. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register) · Jaime Luna · 2022 · 9 citations · Cited by this paper
  26. Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study · Phillipe Corcia · 2025 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)